Literature DB >> 15858461

Progress toward interruption of wild poliovirus transmission--worldwide, January 2004-March 2005.

.   

Abstract

In 1988, the World Health Assembly of the World Health Organization (WHO) resolved to eradicate poliomyelitis globally. Since then, substantial worldwide progress has been made toward that goal; the number of countries where polio is endemic declined from 125 in 1988 to six by the end of 2003. Further progress in 2004 toward interruption of transmission has continued in the three Asian countries where polio is endemic (Afghanistan, India, and Pakistan). However, in 2003, two countries in Africa experienced a resurgence of polio cases; the resurgence continued to spread in 2004 from the Nigeria-Niger endemic reservoir to involve a total of 14 countries that had not reported polio > or =1 year. Local transmission of wild poliovirus (WPV) has been reestablished in six of these 14 countries, including Sudan, where a major outbreak occurred. This report describes global efforts to eradicate polio during January 2004-March 2005 and outlines remaining challenges to interrupting transmission in countries where polio remains endemic or transmission has been reestablished.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858461

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

1.  Molecular characterization of wild-type polioviruses isolated in Greece during the 1996 outbreak in Albania.

Authors:  Zaharoula Kyriakopoulou; Christine Kottaridi; Evaggelos Dedepsidis; Eugenia Bolanaki; Stamatina Levidiotou-Stefanou; Panayotis Markoulatos
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  Mass public health programmes and the obligations of sponsoring and participating organisations.

Authors:  A Dawson; Y Paul
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

Review 3.  Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status.

Authors:  T Jacob John; Vipin M Vashishtha
Journal:  Indian J Med Res       Date:  2013-05       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.